[NKTR] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[NKTR] Nektar Therapeutics
Announcement Date
05-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 8.20%
YoY- 29.50%
Quarter Report
NKTR's Result
NKTR's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 23,885 22,023 25,009 23,462 33,862 39,826 95,466 -20.61%
PBT -42,108 -56,544 -145,649 -117,075 -111,886 -100,050 -33,644 3.80%
Tax -29 3,144 -4 128 278 -1,838 182 -
NP -42,079 -59,688 -145,645 -117,203 -112,164 -98,212 -33,826 3.70%
Tax Rate - - - - - - - -
Total Cost 65,964 81,711 170,654 140,665 146,026 138,038 129,292 -10.60%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -176.17 -271.03 -582.37 -499.54 -331.24 -246.60 -35.43 30.62%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.22 -0.32 -0.79 -0.65 -0.64 -0.57 -0.21 0.77%
EPS Diluted -0.22 -0.32 -0.79 -0.65 -0.64 -0.57 -0.21 0.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.